260 related articles for article (PubMed ID: 36380859)
21. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
[TBL] [Abstract][Full Text] [Related]
22. Circulating tumor cells
Nicolò E; Gianni C; Pontolillo L; Serafini MS; Munoz-Arcos LS; Andreopoulou E; Curigliano G; Reduzzi C; Cristofanilli M
Transl Breast Cancer Res; 2024; 5():10. PubMed ID: 38751670
[TBL] [Abstract][Full Text] [Related]
23. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.
Fernandez SV; Bingham C; Fittipaldi P; Austin L; Palazzo J; Palmer G; Alpaugh K; Cristofanilli M
Breast Cancer Res; 2014 Oct; 16(5):445. PubMed ID: 25307991
[TBL] [Abstract][Full Text] [Related]
24. Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?
Słomka A; Wang B; Mocan T; Horhat A; Willms AG; Schmidt-Wolf IGH; Strassburg CP; Gonzalez-Carmona MA; Lukacs-Kornek V; Kornek MT
Theranostics; 2022; 12(13):5836-5855. PubMed ID: 35966579
[TBL] [Abstract][Full Text] [Related]
25. Integrative diagnosis of cancer by combining CTCs and associated peripheral blood cells in liquid biopsy.
Zhang WW; Rong Y; Liu Q; Luo CL; Zhang Y; Wang FB
Clin Transl Oncol; 2019 Jul; 21(7):828-835. PubMed ID: 30569214
[TBL] [Abstract][Full Text] [Related]
26. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.
Liu W; Vivian CJ; Brinker AE; Hampton KR; Lianidou E; Welch DR
Cancer Microenviron; 2014 Dec; 7(3):117-31. PubMed ID: 24938990
[TBL] [Abstract][Full Text] [Related]
27. Current status of liquid biopsies for the detection and management of prostate cancer.
Lu YT; Delijani K; Mecum A; Goldkorn A
Cancer Manag Res; 2019; 11():5271-5291. PubMed ID: 31239778
[TBL] [Abstract][Full Text] [Related]
28. Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer.
Mariscal J; Fernandez-Puente P; Calamia V; Abalo A; Santacana M; Matias-Guiu X; Lopez-Lopez R; Gil-Moreno A; Alonso-Alconada L; Abal M
J Proteome Res; 2019 Mar; 18(3):1043-1053. PubMed ID: 30585730
[TBL] [Abstract][Full Text] [Related]
29. Clinical Significance of Circulating Tumor Cells in Gastrointestinal Carcinomas.
Konczalla L; Wöstemeier A; Kemper M; Karstens KF; Izbicki J; Reeh M
Diagnostics (Basel); 2020 Mar; 10(4):. PubMed ID: 32235479
[TBL] [Abstract][Full Text] [Related]
30. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808
[TBL] [Abstract][Full Text] [Related]
31. Next generation sequencing of glioblastoma circulating tumor cells: non-invasive solution for disease monitoring.
Kolostova K; Pospisilova E; Pavlickova V; Bartos R; Sames M; Pawlak I; Bobek V
Am J Transl Res; 2021; 13(5):4489-4499. PubMed ID: 34150029
[TBL] [Abstract][Full Text] [Related]
32. HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer.
Nanou A; Zeune LL; Bidard FC; Pierga JY; Terstappen LWMM
Breast Cancer Res; 2020 Aug; 22(1):86. PubMed ID: 32787900
[TBL] [Abstract][Full Text] [Related]
33. Expression pattern of androgen receptors, AR-V7 and AR-567es, in circulating tumor cells and paired plasma-derived extracellular vesicles in metastatic castration resistant prostate cancer.
Strati A; Zavridou M; Bournakis E; Mastoraki S; Lianidou E
Analyst; 2019 Nov; 144(22):6671-6680. PubMed ID: 31596277
[TBL] [Abstract][Full Text] [Related]
34. Extracellular Vesicles in Brain Tumor Progression.
D'Asti E; Chennakrishnaiah S; Lee TH; Rak J
Cell Mol Neurobiol; 2016 Apr; 36(3):383-407. PubMed ID: 26993504
[TBL] [Abstract][Full Text] [Related]
35. Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.
Shishido SN; Carlsson A; Nieva J; Bethel K; Hicks JB; Bazhenova L; Kuhn P
J Transl Med; 2019 Aug; 17(1):294. PubMed ID: 31462312
[TBL] [Abstract][Full Text] [Related]
36. Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer.
Cardinali B; De Luca G; Tasso R; Coco S; Garuti A; Buzzatti G; Sciutto A; Arecco L; Villa F; Carli F; Reverberi D; Quarto R; Dono M; Del Mastro L
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682999
[TBL] [Abstract][Full Text] [Related]
37. Circulating tumor cells as "liquid biopsies" to understand cancer metastasis.
Woo D; Yu M
Transl Res; 2018 Nov; 201():128-135. PubMed ID: 30075099
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
[TBL] [Abstract][Full Text] [Related]
39. Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichment.
Smith KJ; Jana JA; Kaehr A; Purcell E; Opdycke T; Paoletti C; Cooling L; Thamm DH; Hayes DF; Nagrath S
Lab Chip; 2021 Sep; 21(18):3559-3572. PubMed ID: 34320046
[TBL] [Abstract][Full Text] [Related]
40. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.
Lin M; Chen JF; Lu YT; Zhang Y; Song J; Hou S; Ke Z; Tseng HR
Acc Chem Res; 2014 Oct; 47(10):2941-50. PubMed ID: 25111636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
